Abstract

The brains of Alzheimer's disease (AD) patients contain large numbers of amyloid plaques that are rich in fibrils composed of 40- and 42-residue amyloid-beta (Abeta) peptides. Several lines of evidence indicate that fibrillar Abeta and especially soluble Abeta aggregates are important in the etiology of AD. Recent reports also stress that amyloid aggregates are polymorphic and that a single polypeptide can fold into multiple amyloid conformations. Here we demonstrate that Abeta-(1-40) can form soluble aggregates with predominant beta-structures that differ in stability and morphology. One class of aggregates involved soluble Abeta protofibrils, prepared by vigorous overnight agitation of monomeric Abeta-(1-40) at low ionic strength. Dilution of these aggregation reactions induced disaggregation to monomers as measured by size exclusion chromatography. Protofibril concentrations monitored by thioflavin T fluorescence decreased in at least two kinetic phases, with initial disaggregation (rate constant approximately 1 h(-1)) followed by a much slower secondary phase. Incubation of the reactions without agitation resulted in less disaggregation at slower rates, indicating that the protofibrils became progressively more stable over time. In fact, protofibrils isolated by size exclusion chromatography were completely stable and gave no disaggregation. A second class of soluble Abeta aggregates was generated rapidly (<10 min) in buffered 2% hexafluoroisopropanol (HFIP). These aggregates showed increased thioflavin T fluorescence and were rich in beta-structure by circular dichroism. Electron microscopy and atomic force microscopy revealed initial globular clusters that progressed over several days to soluble fibrous aggregates. When diluted out of HFIP, these aggregates initially were very unstable and disaggregated completely within 2 min. However, their stability increased as they progressed to fibers. Relative to Abeta protofibrils, the HFIP-induced aggregates seeded elongation by Abeta monomer deposition very poorly. The techniques used to distinguish these two classes of soluble Abeta aggregates may be useful in characterizing Abeta aggregates formed in vivo.

Highlights

  • Alzheimer’s disease (AD)1 is one of a number of diseases in which proteins form amyloid aggregates

  • Whereas early evidence suggested that A␤ fibrils initiate a cascade of events that result in neuronal cell death (8), a number of investigators propose that soluble aggregates of A␤, rather than monomers or insoluble amyloid fibrils, may be responsible for synaptic dysfunction in AD (9 –13)

  • This proposal is supported by observations that soluble aggregates generated in vitro from synthetic A␤-(1– 40) and -(1– 42) induced toxicity in cultured cells (10, 14), that soluble A␤ aggregates produced in cell culture markedly inhibited hippocampal long term potentiation in rats in vivo (15), and that transgenic mice expressing human A␤ show functional deficits that precede extracellular deposition of fibrillar A␤ (12, 16)

Read more

Summary

Introduction

Alzheimer’s disease (AD)1 is one of a number of diseases in which proteins form amyloid aggregates. Two types of amyloid fibrils were formed by A␤-(1– 40) following aggregation under mildly agitated or quiescent conditions, and chemical shift and line width data from solid-state NMR for 33 of the 40 residues indicated different underlying structures (29).2

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call